These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer. Dalin MG, Desrichard A, Katabi N, Makarov V, Walsh LA, Lee KW, Wang Q, Armenia J, West L, Dogan S, Wang L, Ramaswami D, Ho AL, Ganly I, Solit DB, Berger MF, Schultz ND, Reis-Filho JS, Chan TA, Morris LG. Clin Cancer Res; 2016 Sep 15; 22(18):4623-33. PubMed ID: 27103403 [Abstract] [Full Text] [Related]
3. Molecular characterization of apocrine salivary duct carcinoma. Chiosea SI, Williams L, Griffith CC, Thompson LD, Weinreb I, Bauman JE, Luvison A, Roy S, Seethala RR, Nikiforova MN. Am J Surg Pathol; 2015 Jun 15; 39(6):744-52. PubMed ID: 25723113 [Abstract] [Full Text] [Related]
5. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications. Santana T, Pavel A, Martinek P, Steiner P, Grossmann P, Baněčková M, Skálová A. Hum Pathol; 2019 Nov 15; 93():37-47. PubMed ID: 31437521 [Abstract] [Full Text] [Related]
6. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations. Chiosea SI, Thompson LD, Weinreb I, Bauman JE, Mahaffey AM, Miller C, Ferris RL, Gooding WE. Cancer; 2016 Oct 15; 122(20):3136-3144. PubMed ID: 27379604 [Abstract] [Full Text] [Related]
8. Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type. Hsieh MS, Lee YH, Jin YT, Kuo YJ. Virchows Arch; 2020 Oct 15; 477(4):581-592. PubMed ID: 32383006 [Abstract] [Full Text] [Related]
10. Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment. Nakaguro M, Tada Y, Faquin WC, Sadow PM, Wirth LJ, Nagao T. Cancer Cytopathol; 2020 Oct 15; 128(10):693-703. PubMed ID: 32421944 [Abstract] [Full Text] [Related]
13. Genomic alteration in rare subtype of sarcomatoid salivary duct carcinoma. Jeong JS, Cho KJ, Kim D, Lee YS, Song JS. Pathol Res Pract; 2021 Dec 15; 228():153678. PubMed ID: 34781210 [Abstract] [Full Text] [Related]
15. MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas. Grünewald I, Trautmann M, Busch A, Bauer L, Huss S, Schweinshaupt P, Vollbrecht C, Odenthal M, Quaas A, Büttner R, Meyer MF, Beutner D, Hüttenbrink KB, Wardelmann E, Stenner M, Hartmann W. Oncotarget; 2016 Nov 15; 7(46):75261-75272. PubMed ID: 27662657 [Abstract] [Full Text] [Related]
16. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy. Saintigny P, Mitani Y, Pytynia KB, Ferrarotto R, Roberts DB, Weber RS, Kies MS, Maity SN, Lin SH, El-Naggar AK. Cancer; 2018 Sep 15; 124(18):3693-3705. PubMed ID: 30289966 [Abstract] [Full Text] [Related]
18. Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial Carcinoma. Lubin D, Toorens E, Zhang PJ, Jaffer S, Baraban E, Bleiweiss IJ, Nayak A. Am J Surg Pathol; 2019 Jul 15; 43(7):1005-1013. PubMed ID: 31094929 [Abstract] [Full Text] [Related]
19. Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations. Luk PP, Weston JD, Yu B, Selinger CI, Ekmejian R, Eviston TJ, Lum T, Gao K, Boyer M, O'Toole SA, Clark JR, Gupta R. Head Neck; 2016 Apr 15; 38 Suppl 1():E1838-47. PubMed ID: 26699379 [Abstract] [Full Text] [Related]